Landmark Financial Advisors, LLC Synthetic Biologics, Inc. Transaction History

Landmark Financial Advisors, LLC

  • $271 Million
  • Q4 2023

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 03, 2022
SELL
$1.9 - $2.9 $2,280 - $3,480
-1,200 Reduced 4.96%
23,000 $5,000
Q4 2021

Jan 26, 2022
BUY
$2.7 - $4.5 $65,340 - $108,900
24,200 New
24,200 $7,000

About Synthetic Biologics, Inc.

SYN Quotes by TradingView
  • Ticker SYN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,844,100
  • Market Cap $9.51M
  • Description
  • Synthetic Biologics, Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in gastrointestinal (GI) tract for the prevention of microbiome damage, clostridium difficile...
More about SYN
Track This Portfolio

Track Landmark Financial Advisors, LLC Portfolio

Follow Landmark Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Landmark Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Landmark Financial Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email